About Baxalta
Baxalta: A Leading Pharmaceutical Company Committed to Improving Lives
Baxalta is a global pharmaceutical company that is dedicated to improving the lives of patients by developing innovative and life-changing medicines. The company was founded in 2015 as a spin-off from Baxter International, and it has since become one of the leading players in the industry.
At Baxalta, we are committed to research and development, which drives our mission to bring better health and a brighter future to patients. We believe that science can make a real difference in people's lives, and we are constantly working on new ways to translate scientific breakthroughs into effective treatments.
Our focus on innovation has led us to develop some of the most advanced therapies for rare diseases, hematology, immunology, oncology, and other areas. Our portfolio includes products such as ADYNOVATE®, GAMMAGARD LIQUID®, HYQVIA®, OBIZUR®, RIXUBIS®, SHP655 (ADAMTS13), VONVENDI® von Willebrand factor (Recombinant), among others.
We understand that every patient is unique, which is why we strive to provide personalized solutions that meet their specific needs. Our team of experts works closely with healthcare professionals around the world to ensure that our products are safe and effective for all patients.
In addition to our commitment to research and development, Baxalta also places great importance on sustainability. We recognize our responsibility towards society and the environment; therefore we have implemented various initiatives aimed at reducing our environmental impact while promoting social welfare.
Our employees are passionate about making a difference in people's lives through their work at Baxalta. They come from diverse backgrounds but share a common goal: improving patient outcomes through innovative therapies.
In conclusion, Baxalta is an industry leader committed not only developing innovative medicines but also making them accessible for all those who need them worldwide while being socially responsible towards society & environment.